Baxter International (BAX) Gains from Sales and Divestitures (2010 - 2018)
Baxter International (BAX) reported Gains from Sales and Divestitures of $1.0 million for Q4 2018, up 428.35% year-over-year from $194000.0 in Q4 2017, and up 428.35% quarter-over-quarter from $194000.0 in Q4 2017.
Baxter International (BAX) Gains from Sales and Divestitures (2010 - 2018) Analysis & Trends
Baxter International (BAX) has 9 years of Gains from Sales and Divestitures data on file, last reported at $1.0 million in Q4 2018.
- Gains from Sales and Divestitures for Q4 2018 came in at $1.0 million, up 428.35% year-over-year; the trailing twelve-month figure through Dec 2018 was $1.0 million (up 428.35% YoY), and the FY2018 annual result was $1.0 million, up 428.35% from the prior year.
- Gains from Sales and Divestitures grew to $1.0 million in Q4 2018 per BAX's latest filing, from $194000.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $1.3 million in Q4 2016 and troughed at $194000.0 in Q4 2017.
- A 5-year average of $778400.0 and a median of $1.0 million in 2018 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2017 and 2018: Gains from Sales and Divestitures plunged 84.74% in 2017, then jumped 428.35% in 2018.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $360000.0 in 2014, then soared by 189.44% to $1.0 million in 2015, then gained by 21.98% to $1.3 million in 2016, then sank by 84.74% to $194000.0 in 2017, then jumped by 428.35% to $1.0 million in 2018.
- Business Quant data shows BAX's Gains from Sales and Divestitures at $1.0 million in Q4 2018, $194000.0 in Q4 2017, and $1.3 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.03 Mn |
| Dec 31, 2018 | 1.03 Mn |
| Dec 31, 2017 | 194,000.00 |
| Dec 31, 2017 | 194,000.00 |
| Dec 31, 2016 | 1.27 Mn |
| Dec 31, 2016 | 1.27 Mn |
| Dec 31, 2015 | 1.04 Mn |
| Dec 31, 2015 | 1.04 Mn |
| Dec 31, 2014 | 360,000.00 |
| Dec 31, 2014 | 360,000.00 |
| Dec 31, 2013 | 387,000.00 |
| Dec 31, 2013 | 387,000.00 |
| Dec 31, 2012 | 348,000.00 |
| Dec 31, 2012 | 348,000.00 |
| Dec 31, 2011 | 409,000.00 |
| Dec 31, 2011 | 409,000.00 |
| Dec 31, 2010 | -168,000.00 |
| Dec 31, 2010 | -168,000.00 |